{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:37:23Z","timestamp":1785609443341,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010570","name":"Nieders\u00e4chsisches Ministerium f\u00fcr Wissenschaft und Kultur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010570","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ejpb.2020.04.021","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:08:17Z","timestamp":1588540097000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development"],"prefix":"10.1016","volume":"152","author":[{"given":"Stefan","family":"Czyz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Henrik","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Kwade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"van Eerdenbrugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Juhnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Bunjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.04.021_b0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Tox. Met."},{"key":"10.1016\/j.ejpb.2020.04.021_b0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2010.10.012","article-title":"Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles","volume":"77","author":"Juenemann","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0015","first-page":"82","article-title":"Poor aqueous solubility - an industry wide problem in drug discovery","volume":"5","author":"Lipinski","year":"2002","journal-title":"Am. Pharmaceut. Rev."},{"key":"10.1016\/j.ejpb.2020.04.021_b0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.04.021_b0025","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solution","volume":"19","author":"Noyes","year":"1897","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2020.04.021_b0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1515\/zpch-1904-4704","article-title":"Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen","volume":"47 A","author":"Nernst","year":"1904","journal-title":"Z. Phys. Chem."},{"key":"10.1016\/j.ejpb.2020.04.021_b0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1515\/zpch-1904-4705","article-title":"Reaktionsgeschwindigkeit in heterogenen Systemen","volume":"43","author":"Brunner","year":"1904","journal-title":"Z. Phys. Chem."},{"key":"10.1016\/j.ejpb.2020.04.021_b0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2012.09.034","article-title":"Drug nanocrystals in the commercial pharmaceutical development process","volume":"453","author":"M\u00f6schwitzer","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","article-title":"Physical and chemical stability of drug nanoparticles","volume":"63","author":"Wu","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.04.021_b0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijpharm.2012.07.015","article-title":"Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations","volume":"453","author":"Paudel","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejps.2008.06.009","article-title":"Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion","volume":"35","author":"van Eerdenbrugh","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.04.021_b0060","series-title":"Spray Drying in Practice","author":"Masters","year":"2002"},{"key":"10.1016\/j.ejpb.2020.04.021_b0065","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/jps.24015","article-title":"Preparation and solidification of redispersible nanosuspensions","volume":"103","author":"Zhang","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.04.021_b0070","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1007\/s11095-008-9625-0","article-title":"Conversion of nanosuspensions into dry powders by spray drying: A case study","volume":"25","author":"Chaubal","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.04.021_b0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2012.11.044","article-title":"Formulation and drying of miconazole and itraconazole nanosuspensions","volume":"443","author":"Cerdeira","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejpb.2017.01.024","article-title":"How sugars protect proteins in the solid state and during drying (review): Mechanisms of stabilization in relation to stress conditions","volume":"114","author":"Mensink","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing - oral formulation development and biopharmaceutical evaluation","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.04.021_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apt.2010.09.011","article-title":"Progress in developing spray-drying methods for the production of controlled morphology particles: From the nanometer to submicrometer size ranges","volume":"22","author":"Nandiyanto","year":"2011","journal-title":"Adv. Powder Technol."},{"key":"10.1016\/j.ejpb.2020.04.021_b0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.powtec.2018.09.096","article-title":"Application of quality by design for optimization of spray drying process used in drying of risperidone nanosuspension","volume":"342","author":"Nair","year":"2019","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2020.04.021_b0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2011.04.034","article-title":"Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility","volume":"413","author":"Mou","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2015.09.013","article-title":"Nanoparticle agglomerates of indomethacin: The role of poloxamers and matrix former on their dissolution and aerosolisation efficiency","volume":"495","author":"Malamatari","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0110","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ceat.201000062","article-title":"Accelerated formulation development for nanomilled active pharmaceutical ingredients using a screening approach","volume":"33","author":"Juhnke","year":"2010","journal-title":"Chem. Eng. Technol."},{"key":"10.1016\/j.ejpb.2020.04.021_b0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijpharm.2013.06.050","article-title":"Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer\/drug property","volume":"454","author":"Yue","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0120","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ppsc.200290006","article-title":"Determination of the refractive index of water-dispersible granules for use in laser diffraction Experiments","volume":"19","author":"Saveyn","year":"2002","journal-title":"Part Part Sys. Chart."},{"key":"10.1016\/j.ejpb.2020.04.021_b0125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ceat.201300697","article-title":"Challenges in nanogrinding of active pharmaceutical ingredients","volume":"37","author":"Bitterlich","year":"2014","journal-title":"Chem. Eng. Technol."},{"key":"10.1016\/j.ejpb.2020.04.021_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jps.10513","article-title":"Visualization of the crystallization of lactose from the amorphous state","volume":"93","author":"Price","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.04.021_b0135","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.carres.2010.06.011","article-title":"The use of dynamic vapour sorption methods for the characterisation of water uptake in amorphous trehalose","volume":"345","author":"Hunter","year":"2010","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejpb.2020.04.021_b0140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/07373930802716391","article-title":"Crystallization rates for amorphous sucrose and lactose powders from spray drying: A Comparison","volume":"27","author":"Langrish","year":"2009","journal-title":"Dry Technol."},{"key":"10.1016\/j.ejpb.2020.04.021_b0145","doi-asserted-by":"crossref","DOI":"10.1023\/A:1018941810744","article-title":"The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids","volume":"11","author":"Hancock","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.04.021_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0008-6215(93)87004-C","article-title":"Melting and glass transitions of low molecular weight carbohydrates","volume":"238","author":"Roos","year":"1993","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejpb.2020.04.021_b0155","doi-asserted-by":"crossref","first-page":"19678","DOI":"10.1021\/jp063134t","article-title":"Glass transition temperature of glucose, sucrose, and trehalose: an experimental and in silico study","volume":"110","author":"Simperler","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2020.04.021_b0160","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1051\/lait:2002025","article-title":"Importance of glass transition and water activity to spray drying and stability of dairy powders","volume":"82","author":"Roos","year":"2002","journal-title":"Lait"},{"key":"10.1016\/j.ejpb.2020.04.021_b0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2013.07.021","article-title":"Preparation and in vitro\/in vivo evaluation of fenofibrate nanocrystals","volume":"455","author":"Zuo","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0170","first-page":"926","article-title":"Formation of mefenamic acid nanocrystals with improved dissolution characteristics","volume":"3","author":"Konnerth","year":"2017","journal-title":"Chem.-Ing.-Tech."},{"key":"10.1016\/j.ejpb.2020.04.021_b0175","series-title":"Nanozerkleinerung Pharmazeutischer Wirkstoffe in Mahlk\u00f6rperm\u00fchlen","author":"Bitterlich","year":"2015"},{"key":"10.1016\/j.ejpb.2020.04.021_b0180","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s11095-014-1567-0","article-title":"Formulation and performance of danazol nano-crystalline suspensions and spray dried powders","volume":"32","author":"Kumar","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.04.021_b0185","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jps.21563","article-title":"A screening study of surface stabilization during the production of drug nanocrystals","volume":"98","author":"van Eerdenbrugh","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.04.021_b0190","first-page":"294","article-title":"Contribution of solid-state properties to the aqueous solubility of drugs","volume":"29","author":"Wassvik","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.04.021_b0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2009.09.041","article-title":"Hydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs","volume":"384","author":"Lee","year":"2010","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:36:52Z","timestamp":1760546212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120301168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":39,"alternative-id":["S0939641120301168"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.04.021","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}